Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

SHA:600521 Revenue

Zhejiang Huahai Pharmaceutical had revenue of 2.34B CNY in the quarter ending March 31, 2026, a decrease of -1.40%. This brings the company's revenue in the last twelve months to 8.55B, down -9.17% year-over-year. In the year 2025, Zhejiang Huahai Pharmaceutical had annual revenue of 8.59B, down -10.06%.

• Revenue (ttm): 8.55B
• Revenue Growth: -9.17%
• P/S Ratio: 2.51
• Revenue / Employee: 972.37K
• Employees: 8,797
• Market Cap: 21.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.59B	-960.28M	-10.06%
Dec 31, 2024	9.55B	1.24B	14.91%
Dec 31, 2023	8.31B	42.97M	0.52%
Dec 31, 2022	8.27B	1.62B	24.42%
Dec 31, 2021	6.64B	158.36M	2.44%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error